Rationale design of pancreatic a-amylase inhibitor
Type 2 diabetes mellitus is a chronic metabolic disorder characterized by loss of glycaemic control. Despite the increasing incidence of type 2 diabetes mellitus, limited oral antidiabetic agents are available. Furthermore, the potency of some drugs is unjustifiable due to the level of side-effects....
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/63147 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|